Jinzhou Jiutai Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical company with a production history of more than 70 years. The predecessor, Jinzhou Pharmaceutical Factory, was first established in 1951 and was reorganized into Jinzhou Jiutai Pharmaceutical Co., Ltd. in 1998. It is one of the key pharmaceutical companies in Liaoning Province.

The company covers an area of ​​58,000 square meters, has a registered capital of 40.46 million yuan, and currently has 1,250 employees, including 310 engineering and technical personnel. It has 5 production workshops, 1 R&D center, and 1 controlled pharmaceutical commercial company. The company has nearly 100 kinds of products, and the "chlorhexidine" raw materials are domestic manufacturers. The suppository products that use it as raw materials have formed a series of products covering the whole country; solid preparation products have formed two series of antipyretic analgesics and digestive system drugs. ; Powder injection "pantoprazole sodium for injection" is a four-category new drug in the country, and has good effect in treating peptic ulcers. The company's gynecological medicine is the "gynecological medicine production base" designated by the former State Administration of Medicine. The company's product structure is reasonable and its economic operation is good. Advanced production technology, mature process routes, complete quality monitoring system, stable and reliable product quality.

Jiutai Pharmaceutical Company is a provincial enterprise technology research and development center. Over the years, the company has successfully developed chlorhexidine, maloteester, omeprazole sodium, pantoprazole sodium, betastine hydrochloride, ethylenediamine diacetamide acetate, polyhexamethylenebiguanide hydrochloric acid There are more than a dozen preparations such as salt (PHMB) and three-flavor hemorrhoid suppositories, chlorhexidine suppositories, metronidazole furazolidone suppositories (Jiutai Kunbao), azithromycin fumarate capsules. Four major series of products represented by chlorhexidine raw materials, gynecological suppositories, anti-peptic ulcer drugs, and antipyretic analgesics.

In recent years, in accordance with the spirit of deepening the reform of state-owned enterprises, Jiutai Pharmaceutical has vigorously promoted mechanism innovation, management and technological innovation, and led the overall situation with innovative work. In July 2011, the company carried out asset restructuring, further optimized the structure of various resource elements of the enterprise, accelerated the innovation of the enterprise, fully utilized the potential of the enterprise and employees, and improved the production efficiency and competitiveness of the enterprise. Maintain the long-term development of the enterprise. In order to improve the production technology level and the development of new products, the company has gathered outstanding pharmacy talents from China Pharmaceutical University, Shenyang Pharmaceutical University, Jiamusi Medical College and other universities, and has successively introduced advanced production from Japan, the United Kingdom, Italy and other countries. equipment.

In the business field, the company takes "user first" as its purpose and "sincere and friendly, mutual benefit and win-win" as its starting point, paying attention to contracts and keeping trustworthy. The company has a capable sales team and a solid sales network. Products are sold all over the country, and some are sold to Europe and the United States.